ATE311904T1 - Halbfester verabreichungsträger und arzneimittel - Google Patents

Halbfester verabreichungsträger und arzneimittel

Info

Publication number
ATE311904T1
ATE311904T1 AT01935418T AT01935418T ATE311904T1 AT E311904 T1 ATE311904 T1 AT E311904T1 AT 01935418 T AT01935418 T AT 01935418T AT 01935418 T AT01935418 T AT 01935418T AT E311904 T1 ATE311904 T1 AT E311904T1
Authority
AT
Austria
Prior art keywords
semi
medicinal product
administration carrier
solid administration
solid
Prior art date
Application number
AT01935418T
Other languages
English (en)
Inventor
Steven Y Ng
Hui-Rong Shen
Jorge Heller
Original Assignee
Ap Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ap Pharma Inc filed Critical Ap Pharma Inc
Application granted granted Critical
Publication of ATE311904T1 publication Critical patent/ATE311904T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01935418T 2000-05-11 2001-05-11 Halbfester verabreichungsträger und arzneimittel ATE311904T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56971700A 2000-05-11 2000-05-11
PCT/US2001/015409 WO2001085139A2 (en) 2000-05-11 2001-05-11 Semi-solid delivery vehicle and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE311904T1 true ATE311904T1 (de) 2005-12-15

Family

ID=24276565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01935418T ATE311904T1 (de) 2000-05-11 2001-05-11 Halbfester verabreichungsträger und arzneimittel

Country Status (8)

Country Link
EP (1) EP1280558B1 (de)
AT (1) ATE311904T1 (de)
AU (1) AU2001261516A1 (de)
CA (1) CA2445638C (de)
DE (1) DE60115631T2 (de)
DK (1) DK1280558T3 (de)
ES (1) ES2253381T3 (de)
WO (1) WO2001085139A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
AU2001288829A1 (en) 2000-09-06 2002-03-22 Ap Pharma, Inc. Degradable polyacetal polymers
US20020176844A1 (en) * 2001-05-11 2002-11-28 Ng Steven Y. Bioerodible polyorthoesters containing hydrogen bonding groups
EP1395626A1 (de) * 2001-05-11 2004-03-10 AP Pharma, Inc. Peg-poe, peg-poe-peg, und oe-peg-poe- blockcopolymere
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US7045589B2 (en) 2002-11-15 2006-05-16 A.P. Pharma, Inc. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US7875697B2 (en) 2006-06-29 2011-01-25 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
US7592458B2 (en) 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US8940315B2 (en) 2008-04-18 2015-01-27 Medtronic, Inc. Benzodiazepine formulation in a polyorthoester carrier
AU2014228313B2 (en) * 2013-03-15 2019-01-17 Heron Therapeutics, Inc. Compositions of a polyorthoester and an aprotic solvent
JP6723162B2 (ja) * 2014-04-21 2020-07-15 ヘロン セラピューティクス， インコーポレイテッドＨｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． ポリオルトエステルおよび有機酸添加剤の組成物
EP4090353A4 (de) 2020-01-13 2023-08-09 Durect Corporation Arzneimittelabgabesysteme mit verzögerter freisetzung mit reduzierten verunreinigungen und verwandte verfahren
CN119463135A (zh) * 2020-07-10 2025-02-18 南京海鲸药业股份有限公司 一种具有酸敏感降解、温敏性质的系列聚合物及其载药组合物
JP2024503402A (ja) 2021-01-12 2024-01-25 デュレクト コーポレーション 徐放性薬物送達システム及び関連の方法
WO2022152835A1 (en) * 2021-01-18 2022-07-21 Evonik Operations Gmbh High molecular weight triethylene-glycol polyorthoester iv (teg-poe iv) polymers and compositions for drug delivery and medical implants applications
EP4538310A1 (de) * 2022-01-20 2025-04-16 Nanjing Fantai Chemical Pharmaceutical Research Institute Serie von polymeren mit säureempfindlichen abbau- und temperaturempfindlichkeitseigenschaften und zusammensetzung zur beladung mit arzneimitteln daraus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT99989A (pt) * 1991-01-09 1994-05-31 Alza Corp Dispositivos biodegradaveis e composicoes para libertacao difusivel de agentes
MY113268A (en) * 1992-12-29 2002-01-31 Insite Vision Incorporated Plasticized bioerodible controlled delivery system
US5968543A (en) * 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US5939453A (en) * 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers

Also Published As

Publication number Publication date
EP1280558A2 (de) 2003-02-05
WO2001085139A3 (en) 2002-04-18
AU2001261516A1 (en) 2001-11-20
EP1280558B1 (de) 2005-12-07
CA2445638A1 (en) 2001-11-15
DE60115631T2 (de) 2006-08-10
WO2001085139A2 (en) 2001-11-15
ES2253381T3 (es) 2006-06-01
CA2445638C (en) 2010-02-09
DK1280558T3 (da) 2005-12-27
DE60115631D1 (de) 2006-01-12

Similar Documents

Publication Publication Date Title
ATE311904T1 (de) Halbfester verabreichungsträger und arzneimittel
TW200616650A (en) Semi-solid delivery vehicle and pharmaceutical compositions
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
DE60021059D1 (de) Hydrogelpartikel formulierungen
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
ATE299740T1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
ATE450252T1 (de) Arzneimittel-mikroteilchen
DK1455888T3 (da) Topisk indgivelsesindretning
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
BR0313575A (pt) Método de transporte transdermal de produtos farmacêuticos topicamente administrados, veìculo, composição de veìculo, composição farmacêutica e uso de um ou mais complexos de derivados de fosfato de compostos farmaceuticamente aceitáveis lipofìlicos com outros excipientes
ATE292453T1 (de) Antivirale arznei
WO2007133751A3 (en) Base-stabilized polyorthoester formulations
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
AR008886A1 (es) Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
ATE356637T1 (de) Supramolekulare komplexe enthaltende arzneimittel
RU94016184A (ru) Противоаллергическая композиция для местного глазного применения, способ ее получения
BR0109747A (pt) Uso de 5-(2-pirazinil)-4-metil-1-2-ditiol-3-tiona (oltipraz) como um medicamento, composição farmacêutica para a prevenção e tratamento da progressão da fibrose hepática, uso de 5-(2-pirazinil)-4-metil-1, 2-ditiol-3-tiona e método para a prevenção e tratamento da progressão da fibrose e da cirrose hepática
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
ATE177638T1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
EP1283040A4 (de) Orale heilmittelform für dauerverabreichung
ATE295169T1 (de) Arzneimittel gegen infertilität, die mit endometriose assoziiert ist
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
SE9904132D0 (sv) Pharmaceutical composition for treatment of diarrhea

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1280558

Country of ref document: EP